Several months ago, when the pandemic disrupted production at US meatpacking plants and caused panic about a potential meat shortage, some consumers may have turned toward plant-based alternatives from Beyond Meat, Impossible Foods and others.
But many might not know about the burgeoning lab-grown meat industry, and the companies looking to deliver a knock-out product designed to dethrone the likes of a filet mignon or T-bone steak.
The pandemic-induced panic around meat production could have posed a unique opportunity for many cultivated meat startups to make their way into the industry limelight as viable protein alternatives. But at this point in their journeys, many of those companies are years away from having anything market-ready, and consumers will likely have to wait awhile to see lab-grown chorizo or cultured salmon on their dinner plates.
This article will be featured in the upcoming edition of the Private Market PlayBook magazine, due out in October. Click here to get a free subscription.
"Novel technologies in the past, such as cell phones, took awhile to fully enter the market in a very significant way, and it is going to take a long time for the benefits of cultivated meat to reach a tipping point and become ubiquitous," said Nick Cooney, managing partner at Lever VC, an investor in alternative protein companies.
That's partially because the production of such a game-changing product requires the right recipe: streamlined technology, good flavor and a retail cost that can compete with conventional beef, chicken, pork and fish. Many startups in the space just aren't quite ready to deliver their product at scale yet.
So what else has prevented meat-loving customers from seeing lab-grown chicken, pork or beef on the shelves of their local grocery stores?
Many alternative food startups get one real shot at convincing their target audience to warm up to an innovative product. And many of them don't necessarily want to reach the market first with only an average product. They want an exceptional one.
"It is very important to make sure that we launch a good product and we are not rushing to release," said Aleph Farms co-founder and CEO Didier Toubia. "Culinary and sensory qualities are as important as nutritional value."
Aleph Farms hopes to develop cultivated beef steaks by mimicking cows' muscle-tissue regeneration. The Israel-based company grabbed headlines in October 2019 when it became the first company to produce meat in a 3D bioprinting experiment on the International Space Station, collaborating with Finless Foods, Russia-based 3D Bioprinting Solutions and others.
One of the biggest challenges facing cultivated meat products is the replication of conventional meat's texture, taste and nutritional characteristics.
For startups, that means lots of R&D costs, according to Matthew Walker, managing director at S2G Ventures, a VC firm that invests in sustainable foodtech and agriculture companies.
To develop lab-grown meat, scientists must isolate stem cells from an animal and allow them to multiply in a lab, regenerating muscle, fat and tissues.
A few companies are spending $100 to $150 per pound to develop products, but hope to reduce costs to around $5 to $10 per pound to compete with the conventional animal protein market, Cooney said.
"On average, companies expect about three weeks of production to cultivate the same amount of meat you would get from a beef cow that had to live for 18 months," he said.
To help their cultivated meat products become a household name, some founders are seeking support for technologies and supply-chain processes designed specifically to create their products.
Brian Frank, a general partner at sustainable food-focused firm FTW Ventures, said cultivated meat startups essentially need "Amazon Web Services for biology" to scale production. Processes need to be automated and tracked through software and services, he said.
"Right now, most founders have no one they can go to and say: 'I have the design, can you build an infrastructure and produce the product for me?'" Frank said.
The coronavirus pandemic has raised questions about food sustainability and the reliability of supply chains. That could result in beneficial attention for alternative food startups.
Memphis Meats co-founder Uma Valeti said consumers are now more eager to hear about what cultivated meat startups are doing than they were in the past. That heightened interest has snowballed into venture funding. Venture capital investment in cultivated meat startups for 2020 has so far jumped about 116% compared to last year's total, according to PitchBook data.
Investors have also gauged interest in alternative protein products from market research studies and consumer surveys.
"Consumer feedback has been great for a product that virtually no one has been able to see, taste or touch yet," said Cooney.
Government regulations present another hurdle for startups, as authorities still have a lot of ground to cover in the development of firm frameworks. In March 2019, the US Department of Agriculture and the Food and Drug Administration agreed to share regulatory responsibility for cell-cultured livestock and poultry products in what was a breakthrough for the industry.
The FDA is expected to regulate processes involving cell collection, cell banks and cell growth, while the USDA will oversee the production and labeling of cultivated meat products.
Because most of the product development takes place in a lab, the FDA will play a larger role in cultured meat regulation than it does for conventional meats, which are largely governed by the USDA. And on the flip side, lab-grown meat won't have to go through inspections for things such as bacterial contamination or be subject to slaughter regulations, like conventional meat.
Memphis Meats doesn't have a product on the market yet. But Valeti said that during the pandemic, his team has intentionally made an effort to increase brand awareness by educating consumers about how they create their products, hosting tasting experiences with food experts and using consumer surveys to understand potential demand.
"Consumer polls are helping investors recognize the opportunity of getting behind a scalable product," Valeti said.
But will that exposure among investors ultimately translate into mass production?
Cell-based meat companies won't just have to compete with the skyrocketing popularity of plant-based products. They'll also face consumer skepticism around whether lab-grown meat can be just as good as conventional meat, and whether it will whet their appetites in the same way.
"Cultivated meat companies will need to do a good job of making clear to consumers that their products are real meat and not another plant-based replica," Cooney said.
Despite a rise in demand for plant-based products, BlueNalu president and CEO Lou Cooperhouse remains skeptical, pointing out that while those products offer a vegan solution, they're often made with highly processed ingredients.
"Cell-based meat is the holy grail to make an animal product without an animaltruly, extraordinarily disruptive," he said.
BlueNalu develops cell-based seafood made directly from fish cells and tissue. The company says its products are free of plastics, pathogens, toxins and other contaminants.
Cooperhouse has ambitious goals for his company, and anticipates that in the next five years, its first factory will be producing 10 million pounds of lab-grown fish annually.
That's the kind of production rate that cultivated meat startups will need in order to compete with other, cheaper proteins.
"Most startups are pretty far off from competing with a $2 McDonald's burger, and a lot of work needs to happen to achieve that price point," said Frank. "No one can make a baby in one month."
Feature illustration via Julia Midkiff/PitchBook
Read the rest here:
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
- Is Phenq Right For You? Review The Facts Before Making a ... - Vashon-Maury Island Beachcomber - November 27th, 2023
- Cavityn Reviews - Does It Work? Cheap Scam or Effective ... - The Daily World - November 25th, 2023
- Trend Hunting With Beautystreams At Cosmoprof Asia 2023 - BeautyMatter - November 25th, 2023
- FDA Considers First CRISPR Gene Editing Treatment That May ... - Slashdot - November 25th, 2023
- How Do Plants Determine Where the Light Is Coming From? - Lab Manager Magazine - November 25th, 2023
- Deaths From Coal Pollution Have Dropped, But Emissions May be ... - Slashdot - November 25th, 2023
- Stem cell-based therapies for stroke in newborns - Cochrane - November 23rd, 2023
- Dr Leslie on Outpatient CAR T-Cell Therapy Programs for ... - OncLive - November 23rd, 2023
- Human Milk-Based Therapy May Be Beneficial in Blood Cancers - Curetoday.com - November 23rd, 2023
- Oncological Horizons: The Synergy of Medical and Surgical ... - Cureus - November 23rd, 2023
- Human and environmental safety of carbon nanotubes across their ... - Nature.com - November 23rd, 2023
- Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted ... - BioSpace - November 23rd, 2023
- #HearTheMarsdenKids call on NHS London to reconsider cancer ... - Metro.co.uk - November 23rd, 2023
- Diagnosis and Management of Cardiovascular Risk in Patients with ... - Dove Medical Press - November 23rd, 2023
- BioLineRx Reports Third Quarter 2023 Financial Results and ... - PR Newswire - November 21st, 2023
- Why our Award Winners Beauty Box is the ultimate beauty gift (for ... - Yahoo Singapore News - November 21st, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or ... - Vashon-Maury Island Beachcomber - November 21st, 2023
- Legend Biotech Reports Third Quarter 2023 Results and Recent ... - StreetInsider.com - November 21st, 2023
- Lorenzo's Oil: Can It Really Treat ALD? - Verywell Health - November 19th, 2023
- Doctor Says Living To 120 By End Of Decade Is Possible What's the Secret? - Benzinga - November 19th, 2023
- The week in pharma: action, reaction and insight week to ... - The Pharma Letter - November 19th, 2023
- Race Cannot Be Used To Predict Heart Disease, Scientists Say ... - Slashdot - November 19th, 2023
- SpaceX's Starship Reaches Outer Space Before Intentional ... - Slashdot - November 19th, 2023
- Mesenchymal Stem Cells Market is projected to reach USD 3,319 million by 2030 according to a new research r... - WhaTech Technology and Markets News - November 17th, 2023
- LMRUK: Protecting the next generation through cord blood - Charity Today News - November 17th, 2023
- Anti-aging molecule discovered that extends lifespan - Earth.com - November 17th, 2023
- Montana State researcher envisions living building materials that ... - Montana State University - November 17th, 2023
- OxyHelp Explores the Benefits of Hyperbaric Oxygen Therapy for ... - StreetInsider.com - November 15th, 2023
- Health benefits of bone marrow - Pakistan Observer - November 15th, 2023
- Evolving the standard of care: What is next for functional ... - NeuroNews International - November 15th, 2023
- Affimed Reports Third Quarter 2023 Financial Results and ... - BioSpace - November 15th, 2023
- Meet the World's First Whole-Eye Transplant Recipient - TIME - November 15th, 2023
- Calidi Biotherapeutics Reports Third Quarter 2023 Operating and ... - Business Wire - November 15th, 2023
- 10 Asia-Pacific biotech companies leading innovation in the region - Labiotech.eu - November 15th, 2023
- Fitspresso Reviews (November Update) Natural Ingredients That ... - Bainbridge Island Review - November 15th, 2023
- 2seventy bio Reports Third Quarter Financial Results and Recent ... - Business Wire - November 15th, 2023
- Japan To Create $6.6 Billion Fund To Develop Outer Space Industry ... - Slashdot - November 15th, 2023
- Be The Match, Healthcare Marketing Impact Awards 2023 - Ad Age - November 13th, 2023
- Medicare coverage saves lives. Enrolling shouldn't be this ... - Kevin MD - November 13th, 2023
- Future Ocean Foods: 36 Global Alt-Seafood Startups Form Association To Tackle Overfishing, Microplastics & More - Green Queen Media - November 13th, 2023
- Orchard Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 13th, 2023
- Celebrity doctor reveals Hollywoods hidden trend of stem cell antiaging therapies - Longevity.Technology - November 11th, 2023
- Amazon Expands Healthcare Push With One Medical Benefits For ... - Slashdot - November 11th, 2023
- Bene Meat Technologies becomes the first to receive EU approval ... - Pet Food Processing - November 11th, 2023
- FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma - Yahoo Finance - November 11th, 2023
- MaaT Pharma Provides Third Quarter 2023 Business Update and ... - Business Wire - November 11th, 2023
- IN8bio Reports Third Quarter 2023 Financial Results and Provides ... - GlobeNewswire - November 11th, 2023
- Fast Lean Pro Reviews - Overpriced or Optimal Ingredients That ... - Journal of the San Juan Islands - November 11th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - GlobeNewswire - November 11th, 2023
- Worlds first whole-eye and partial face transplant gives Arkansas man new hope - CNN - November 9th, 2023
- Glowing Fingertips And Green Eyes: First-of-Its-Kind Monkey ... - ScienceAlert - November 9th, 2023
- 10 Natural Body Scrubs That Exfoliate And Invigorate My Skin - PINKVILLA - November 9th, 2023
- CRISPR Therapeutics Provides Business Update and Reports Third ... - StreetInsider.com - November 9th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - StreetInsider.com - November 9th, 2023
Recent Comments